Dog Canine Cognitive Dysfunction Management

Canine cognitive dysfunction (CCD) causes dementia-like symptoms in older dogs. Recognition and management significantly improve quality of life for affected dogs and their owners.

Key Facts

CCD affects an estimated 22% of dogs over 9 years and 68% of dogs over 15 years
Signs follow the DISHAA framework: disorientation, interaction changes, sleep-wake changes, house soiling, activity changes, anxiety
Selegiline (Anipryl) is the only licensed medication specifically for CCD improving dopamine function
Dietary supplementation with antioxidants, omega-3 fatty acids and medium-chain triglycerides shows benefit
Environmental enrichment and mental stimulation may slow cognitive decline in affected dogs

Welfare Considerations

Dogs with CCD experience confusion, anxiety and disrupted sleep that cause distress without them understanding why. Nighttime disorientation with howling and pacing is particularly distressing for both dogs and owners. Management combining medication, dietary support and environmental adaptation maintains quality of life and reduces distress. Regular quality-of-life assessment guides decisions as the condition progresses.

What You Can Do

Discuss selegiline treatment with your vet if your dog shows CCD signs to slow progression
Maintain consistent daily routines and predictable environment to reduce disorientation anxiety
Provide appropriate cognitive enrichment including food puzzles and gentle training appropriate to cognitive ability
Feed a diet with antioxidants, omega-3s and consider MCT-containing therapeutic diets
Monitor quality of life using validated tools and discuss end-of-life decisions with your vet proactively